Related Experiment Video
Updated: Jul 2, 2025

Author Spotlight: Exploring Heat Shock Proteins in Malaria and Tuberculosis Infections
Published on: March 8, 2024
Conserved molecular chaperone PrsA stimulates protective immunity against group A Streptococcus
Chien-Yu Lai1, Jia-Xun Xie2, Meng-Chih Lai2
1Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, 10051, Taiwan.
Group A Streptococcus (GAS) vaccine development is challenging. However, PrsA1 and PrsA2 proteins are highly conserved and show promise as universal vaccine candidates, offering protection against GAS infection.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Group A Streptococcus (GAS) is a major human pathogen causing global health concerns.
- Developing a GAS vaccine is difficult due to diverse M-types and potential cross-reactive immune responses.
- PrsA1 and PrsA2, surface chaperone proteins, are crucial for GAS proteome homeostasis and virulence.
Purpose of the Study:
- To investigate the potential of PrsA1 and PrsA2 as vaccine candidates against GAS infection.
- To assess the conservation, immunogenicity, and protective efficacy of PrsA1 and PrsA2.
Main Methods:
- Analysis of PrsA1 and PrsA2 conservation across GAS isolates.
- Generation and characterization of anti-PrsA1/A2 antibodies for cross-reactivity and opsonophagocytic killing assays.
- Passive antibody transfer and active immunization studies in mouse models of GAS infection.
- Evaluation of immune responses, including Th1-associated IgG isotypes and complement activation.
Main Results:
- PrsA1 and PrsA2 proteins are highly conserved among GAS isolates with minimal amino acid variation.
- Anti-PrsA1/A2 antibodies did not cross-react with human heart proteins and enhanced neutrophil-mediated killing of GAS.
- Passive transfer of anti-PrsA1/A2 antibodies conferred protective immunity in mice.
- Immunization with CFA-adjuvanted PrsA1/A2 induced robust Th1 responses and provided ~70% protection against invasive GAS challenge.
Conclusions:
- PrsA1 and PrsA2 are highly conserved and safe targets for GAS vaccine development.
- Antibodies against PrsA1/A2 effectively neutralize GAS and confer protection.
- PrsA1 and PrsA2 represent promising candidates for a universal GAS vaccine.
More Related Videos
Related Concept Videos
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Molecular Chaperones and Protein Folding
The...
Regulation of the Unfolded Protein Response
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Single-Strand DNA Binding Proteins
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

